Low-grade gliomas in adults.
暂无分享,去创建一个
[1] J. Drake,et al. Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review. , 1993, Neurosurgery.
[2] K. Hoang-Xuan,et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M Teräs,et al. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. , 2000, International journal of radiation oncology, biology, physics.
[4] S. Ashley,et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] A. Karim,et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. , 1996, International journal of radiation oncology, biology, physics.
[6] K. Fulling,et al. The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum , 1985, Cancer.
[7] M. Chintagumpala,et al. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children , 2005, Cancer.
[8] M. Berger,et al. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. , 2001, Journal of neurosurgery.
[9] Mixed oligoastrocytomas: a survival and prognostic factor analysis. , 1994 .
[10] T. Lawrence,et al. Radiotherapy: what can be achieved by technical improvements in dose delivery? , 2005, The Lancet. Oncology.
[11] G. Giles,et al. Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours , 2005, International journal of cancer.
[12] B. Scheithauer,et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Prados,et al. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. , 1994, Journal of neurosurgery.
[14] L. Recht,et al. Low-grade gliomas. , 1995, Neurologic clinics.
[15] S. Gerson. Clinical relevance of MGMT in the treatment of cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] H. Mehdorn,et al. Management of tectal glioma in childhood. , 2005, Pediatric neurology.
[17] A. Twijnstra,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Presenting Symptoms and Imaging of Grade Ii Astrocytoma Supratentorial Grade Ii Astrocytoma: Biological Features and Clinical Course , 2022 .
[18] D. Miller,et al. Cervicomedullary tumors in children , 1994, Neurology.
[19] L. Recht,et al. Suspected low‐grade glioma: Is deferring treatment safe? , 1992, Annals of neurology.
[20] Laurent Capelle,et al. Continuous growth of mean tumor diameter in a subset of grade II gliomas , 2003, Annals of neurology.
[21] D. J. Lacey,et al. Prognostic factors in brainstem gliomas , 1986, Neurology.
[22] P. Wesseling,et al. Molecular pathogenesis of oligodendroglial tumors , 2004, Journal of Neuro-Oncology.
[23] H. B. Marsden,et al. Patterns of multiple primary tumours in patients treated for cancer during childhood. , 1987, British Journal of Cancer.
[24] G. Draper,et al. Incidence of second primary tumours among childhood cancer survivors. , 1987, British Journal of Cancer.
[25] B. Scheithauer,et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] E. Shaw,et al. Prospective clinical trials of intracranial low-grade glioma in adults and children. , 2003, Neuro-oncology.
[27] M. Leach,et al. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy , 2004, British Journal of Cancer.
[28] M. Berger,et al. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas , 1994, Cancer.
[29] G. Reifenberger,et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. , 1994, The American journal of pathology.
[30] M. Berger,et al. Pediatric brain stem tumors: radiographic, pathological, and clinical correlations. , 1983, Neurosurgery.
[31] J. Fazekas,et al. Treatment of grades I and II brain astrocytomas. The role of radiotherapy. , 1977, International journal of radiation oncology, biology, physics.
[32] Edward E Graves,et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. , 2002, International journal of radiation oncology, biology, physics.
[33] J. Cairncross,et al. Low-grade glioma. To treat or not to treat? , 1989, Archives of neurology.
[34] D. Áfra,et al. Supratentorial recurrences of gliomas. Morphological studies in relation to time intervals with astrocytomas , 2005, Acta Neurochirurgica.
[35] W. Shapiro,et al. Low-grade glioma: Supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults , 2004, Current neurology and neuroscience reports.
[36] Allan H Friedman,et al. Phase II trial of temozolomide in patients with progressive low-grade glioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Philippe Cornu,et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. , 2002, International journal of radiation oncology, biology, physics.
[38] L. Deangelis,et al. Long-term outcome of low-grade oligodendroglioma and mixed glioma , 2000, Neurology.
[39] Management and Outcome of Low-Grade Astrocytomas of the Midline in Children , 1993 .
[40] M. Piérart,et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial , 2005, The Lancet.
[41] M. Chiang,et al. Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma , 2005, Journal of Neuro-Oncology.
[42] S. Goldman,et al. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. , 2004, Journal of neurosurgery.
[43] S. Coons,et al. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. , 1997, Neurosurgery.
[44] E. Eskandar,et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2004. A 34-year-old man with a seizure and a frontal-lobe brain lesion. , 2004, The New England journal of medicine.
[45] I. Ercan,et al. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. , 2005, Clinical radiology.
[46] A. Chiò,et al. Prognostic Factors in Oligodendroglioma , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[47] M. Berger,et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. , 2002, Journal of neurosurgery.
[48] M. Citron,et al. Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. , 1992, Cancer research.
[49] D. Kondziolka,et al. Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. , 1995, Journal of neurosurgery.
[50] R. Gonzalez,et al. MRI in treatment of adult gliomas. , 2005, The Lancet. Oncology.
[51] M. Bent. Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies. , 2003 .
[52] M. J. van den Bent,et al. Successful treatment of low‐grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine , 2005, Cancer.
[53] C. Lui,et al. Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma. , 2002, International journal of radiation oncology, biology, physics.
[54] T E Schultheiss,et al. Radiation response of the central nervous system. , 1995, International journal of radiation oncology, biology, physics.
[55] D. Áfra,et al. Recurrent Low-Grade Gliomas: Dedifferentiation and Prospects of Reoperation , 1991 .
[56] J. Jolles,et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study , 2002, The Lancet.
[57] J. Henson,et al. Age-dependent rate of anaplastic transformation in low-grade astrocytoma , 1999, Neurology.
[58] A. Paetau,et al. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients , 2001, Neurology.
[59] A. Karim,et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] J. Kros,et al. Prognostic value of the proliferation‐related antigen Ki‐67 in oligodendrogliomas , 1996, Cancer.
[61] Maurice M. Smith,et al. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. , 1989, Neurosurgery.
[62] K. Shin,et al. Radiation and chemotherapy improve outcome in oligodendroglioma. , 1997, International journal of radiation oncology, biology, physics.
[63] B. Scheithauer,et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[64] Nancy J Fischbein,et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. , 2005, AJNR. American journal of neuroradiology.
[65] Desmond Curran,et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844) , 1998 .
[66] D. Louis,et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.
[67] A. Karim. Cure and Quality of Life After Treatment for Glioma , 1991 .
[68] Akira Yamaura,et al. Treatment of low-grade oligodendroglial tumors without radiotherapy , 2004, Neurology.
[69] J. Crowley,et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. , 1993, Journal of neurosurgery.
[70] B. Fisher,et al. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] E. Shaw,et al. The practical management of low-grade primary brain tumors , 1999 .
[72] K. Sepkowitz,et al. Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] John M Bennett,et al. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] F. Scaravilli,et al. Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. , 1993, Brain : a journal of neurology.
[75] I. Whittle,et al. The dilemma of low grade glioma , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[76] L. Robison,et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[77] E. Zackai,et al. Brainstem tumors in patients with neurofibromatosis type 1 , 1995, Neurology.
[78] Damien Galanaud,et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. , 2003, Journal of neurosurgery.
[79] A. Maia,et al. Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. , 2004, Journal of neurosurgery.
[80] A. Ramaioli,et al. Long-term outcome of oligodendrogliomas , 2004, Neurology.
[81] R. Jain,et al. Direct Infiltration of Brainstem Glioma Along the Cranial Nerves , 2005 .
[82] B. Lorenz,et al. Unilateral adult malignant optic nerve glioma , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[83] T. Gajewski. Temozolomide for melanoma: new toxicities and new opportunities. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[84] E. Alvord,et al. Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. , 1988, Journal of neurosurgery.
[85] I. Petersen,et al. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. , 1992, Cancer research.
[86] C. Avezaat,et al. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery , 1998, Journal of neurology, neurosurgery, and psychiatry.
[87] E. Laws,et al. Low-grade central nervous system tumors. , 2002, Neurosurgical focus.
[88] P. Kleihues. Surgical Pathology of the Nervous System and Its Coverings. Fourth Edition , 2003 .
[89] S. Bielack,et al. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] P. Kelly,et al. Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.
[91] G. Krol,et al. Low-grade oligodendroglioma responds to chemotherapy , 1996, Neurology.
[92] M. Mehta,et al. Neurocognitive sequelae of cancer treatment. , 2002, Neurology.
[93] A. Cianciulli,et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.